Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001550701-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-11-19 | 2025-11-17 | TENX | MCGAULEY THOMAS | Interim CFO | P - Purchase | $7.25 | +6,000 | 1,000 | New | +$43.5K |
| 2025-11-19 | 2025-11-17 | TENX | MCGAULEY THOMAS | Interim CFO | P - Purchase | $7.34 | +2,000 | 2,000 | New | +$14.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | P | A | 5,000 | $7.23 | 5,000 | I | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2025-11-17 | P | A | 1,000 | $7.35 | 1,000 | I By Spouse | — | — | |
| 3 | Common | Common Stock | 2025-11-17 | P | A | 2,000 | $7.34 | 2,000 | D By Child | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |